MedTrace Logo

Pegasys VR: Integrating Virtual Humans in the Treatment of Child Social Anxiety

NCT02816684 · Status: COMPLETED · Phase: PHASE2 · Type: INTERVENTIONAL · Enrollment: 43

Last updated 2018-10-19

No results posted yet for this study

Summary

Among children, social anxiety is a common, severe and chronic disorder. Social Effectiveness Therapy for Children (SET-C) is an empirically supported treatment with significant potential to impact the lives of children with this severe and chronic disorder. The proposed Pegasys-VR™ system will distinctly enhance its utility, as it will allow dissemination to a broad variety of clinical settings including schools as well as traditional outpatient clinics. Its use for the treatment of social skills deficits will offer a superior solution for mental health personnel, solving many of the resource and logistic barriers that they currently face. The final product will address cost and practical issues by disseminating an empirically-supported treatment that was rigorously built and tested. Using VE will make the traditional social skills therapy programs program cost-effective and patient-centric, allowing even clinicians with little background/training in behavior therapy to have tools not typically available to them.

Conditions

  • Anxiety Disorders

Interventions

BEHAVIORAL

Pegasys-VR

Pegasys-VR uses artificially intelligent avatars and serious game technology to assist children in the acquisition and use of social skills.

BEHAVIORAL

Social Effectiveness Therapy for Children

Group social skills training, peer generalization sessions, individual exposure therapy

Sponsors & Collaborators

  • Virtually Better, Inc.

    collaborator INDUSTRY

  • University of Central Florida

    lead OTHER

Principal Investigators

  • Deborah C Beidel, Ph.D. · University of Central Florida

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
TRIPLE
Model
PARALLEL

Eligibility

Min Age
7 Years
Max Age
12 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2016-06-30
Primary Completion
2018-08-31
Completion
2018-08-31

Countries

  • United States

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT02816684 on ClinicalTrials.gov